EQUITIES

Robust. Fundamental. Dynamic.

Our teams exercise independent thought with high conviction, resulting in portfolios that we believe are well positioned to address our clients' challenges – all within robust risk control frameworks.

vd-icon_Currency_CashUSD

$217.4bn
Equities Assets Under Management

vd-icon_People_3_Group v3

153
Equities Investment
Professionals

vd-icon_Bulleye_Target v3

20
Average Years’ Financial
Industry Experience

As at March 31, 2025

<span class="notranslate">no data</span>

$217.4bn
Equities Assets Under Management

153
Equities Investment
Professionals

20
Average Years’ Financial
Industry Experience

As at March 31, 2025

We measure success by a single factor: client outcomes. As a pure asset manager, our sole mission is to deliver consistent long-term risk-adjusted returns that exceed our benchmarks and peers, regardless of the prevailing investment landscape.

Featured strategies

Global Life Sciences

By understanding the science and business of health care, our experienced team seeks to invest in companies addressing unmet medical needs or improving efficiencies.

Global Technology Leaders

A global approach to investing in technology companies from a highly experienced team

Insights

Small caps: Addressing the “stay-private” trend

Companies may be staying private longer, but that doesn’t diminish opportunities to capture early-stage growth in the small-cap universe.

JH Explorer: A firsthand look at the future of treating atrial fibrillation

Scrubbing in to watch multiple pulse field ablation procedures, we learned about the benefits and risks of this exciting new treatment option for AFib patients.

Brandenburg Gate in Berlin

In a changing global economy, non-U.S. equities begin to stand out

Low valuations, accommodative monetary policies, and fiscal spending initiatives are boosting the outlook for ex U.S. stocks.